Identifying patients with Crohn's disease at high risk of primary nonresponse to infliximab using a radiomic-clinical model. - Xuehua Li; Yingkui Zhong; Chenglang Yuan; Jinjiang Lin; Xiaodi Shen; Minyi Guo; Baolan Lu; Jixin Meng; Yangdi Wang; Naiwen Zhang; Zixin Luo; Guimeng Hu; et al. (Int. J. Intell. Syst., 2022)